Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Device Type & Application The global vascular closure devices market will witness a robust CAGR of 7.0%, valued at $0.895 billion in 2021, expected to appreciate and reach $1.761 billion by 2030, confirms Strategic Market Research. The vascular closure device is used to seal small punctures made after an angiography is done in an artery. Vascular closure devices are usually a metallic clip (a piece of collagen or suture). Cardiovascular diseases are the main reason behind the deaths caused due to illness in America. According to the Centers for Diseases Control and Prevention, one person dies every 36 seconds in the United States due to cardiovascular disease. It is estimated that annually 659,00 people die due to cardiovascular diseases in the United States. High prevalence of cardiovascular diseases, a large number of approvals for vascular closure devices, increasing prevalence of obesity, growing geriatric population, increasing focus of market players on large-bore endovascular closure devices, increasing focus on how to reduce blood loss in patients during surgeries, and favorable reimbursement scenarios for interventional radiology procedures are the factors attributed to the growth of the global industry. Key Industry Driver - Rise in Number of Cardiovascular Diseases The rapid increase in the number of cardiovascular diseases (CVDs) globally is the main driver behind the growth of the global market. According to American Heart Association (AHA) reports, approximately 40.5% of the U.S. population will become victims of cardiovascular diseases by 2030. Thus, the increase in the prevalence of cardiovascular diseases, which in turn increases the interventional procedures and catheterization for diagnosing and treating CVDs, is acting as a key driver for the industry. The increasing prevalence of obesity is also a key driving factor for the market's growth. It is because obesity increases the risk of cardiovascular diseases, which in turn is increasing the overall demand for vascular closure devices. According to a Harvard study 2020, two in every three Americans are overweight, and one in every three Americans are obese. It is estimated that by 2030, 1 billion adults will be obese. Another factor contributing to the growth of the vascular closure devices market is the geriatric population. It is expected that by 2030 one in every six individuals will be over 60 years, according to the United Nations Department of Economic and Social Welfare. Restraints - High Costs Involved with Vascular Closure Devices Compared to manual compression devices, vascular closure devices are highly-priced. A manual compression device costs around 15-25 U.S. dollars, while a vascular closure device costs around 150-250 US dollars. Thus, the increase in the healthcare expenditure by patients and vascular closure device complications are the key restraints faced by the industry. Opportunities - Expansion in the Healthcare Industry in Terms of the Number of Hospitals and Surgical Centers Government investments in establishing new hospitals are creating significant opportunities for the market in the future. As per the House of Commons Library, by 2030, as announced by the Prime Minister of the U.K, there will be an investment of around 4.3 billion U.S. dollars in developing 40 hospitals. The key end-users, hospitals, and surgical centers are expected to see massive growth, thus contributing to the industry's growth. Changes in the lifestyle of the people and the adoption of unhealthy habits like alcohol consumption, smoking, physical inactivity, and improper diet are the key reasons for an increase in the number of diseases. According to an article in United Nations, changing lifestyle and unhealthy habits like alcohol consumption, smoking, physical inactivity and improper diet might increase the risk of most common heart diseases by 80%, thereby creating a huge scope for manufacturers to develop innovative cardiac products. Market Analysis Of Different Segments Covered in the Report Based on Type Passive Approximators Collagen Plugs A sealant or Gel-based Devices Compression Assist Devices Active Approximators Suture-based Devices Clip-based Devices External Hemostatic Devices Based on Access Femoral Access Radial Access Based on Procedure Interventional Cardiology Interventional Radiology/Vascular Surgery Based on Region North America US Canada Europe E-3 Rest of Europe Asia Pacific Rest of World Segments Analysis & Insights Based on type, the passive approximators segment dominated the overall market, and it is expected to do so with a CARG of 7.6% throughout the forecasted period. The dominating share of this segment is due to the increasing number of approvals from regulatory bodies for vascular closure devices and the associated advantages, such as a high success rate with these devices. According to an article in Cardiac Interventions, a success rate of 95% can be achieved using vascular closure devices. Based on procedure, the Interventional cardiology segment dominated the overall vascular closure devices market with a steady CAGR throughout the forecasted period. The increasing prevalence of cardiac disorders which require proper diagnosis and treatment using advanced technologies is the reason for the high industry share. As per the Center for Disease Control and Prevention, every year, 363 billion U.S. dollars are spent by the people of the United States for the treatment and diagnosis of cardiovascular diseases. Based on access, the Femoral vascular access segment, with market size of 957 million U.S. dollars in 2020, has witnessed a dominant share. Furthermore, due to high procedural volume, it is forecasted that this segment will grow with a significant CAGR during the forecasted timeline. Based on region, North America dominated the total industry with an overall share of 45% and is anticipated to do so with a steady CAGR throughout the forecasted period. The presence of major hospitalizations, manufacturers, and their R&D investments are the reasons behind the massive market share. Asserted by the Centers for Disease Control and Prevention, over 454,000 hospitalizations with atrial fibrillation are reported annually in the U.S. Global Vascular Closure Devices Market Competitive Landscape Analysis A few of the key players that are mentioned in the report are: Terumo Corporation Abbott Cardinal Health Cardiva Medical, Inc Medtronic Plc Morris Innovative, Inc Teleflex Incorporated Merit Medical Systems, Inc Vasorum Ltd Medical, Inc Vivasure Medical Ltd Tricol Biomedical Vascular Closure Devices Market Report Coverage Report Attribute Details Forecast Period 2021-2030 The market size value in 2021 0.895 billion U.S. dollars The revenue forecast in 2030 1.761 billion U.S. dollars Growth rate 7.0% The base year for estimation 2021 Historical data 2017 - 2020 Unit USD Billion, CAGR (2021-2030) Segmentation Type, Access, Procedure, and Region By Type Passive Approximators (Collagen Plugs, Sealant or Gel-based Devices, Compression Assist Devices), Active Approximators (Suture-based Devices, Clip-based Devices), External Hemostatic Devices By Access Femoral Access, Radial Access By Procedure Interventional Cardiology, Interventional Radiology/Vascular Surgery By Region North America, Asia Pacific, Europe, Rest of the World Country Scope US, Canada, E-3, Rest of Europe Company Usability Profiles Terumo Corporation, Abbott, Cardinal Health, Cardiva Medical, Inc, Medtronic Plc Morris Innovative, Inc, Teleflex Incorporated, Merit Medical Systems, Inc, Vasorum Ltd Medical, Inc, Vivasure Medical Ltd, Tricol Biomedical Recent Developments In July 2021, Vivasure Medical, an Ireland-based vascular closure devices manufacturer, announced the development of PerQseal Blue. PerQseal Blue is a fully bioresorbable and sutureless large-bore venous vascular closure device. This device is expected to be used for transcatheter tricuspid valve repair or replacement (TTVR) and transcatheter mitral valve repair or replacement (TMVR). In April 2021, SiteSeal small vessel vascular closure devices by EnSite Vascular received clearance from U.S. Food and Drug Administration. SiteSeal small vessel vascular closure devices is used after trans brachial endovascular procedure to achieve hemostasis of the brachial artery. In August 2020, a partnership between Veryan Medical and Vasorum was announced to commercialize Celt atrial closure device (ACD) in the United States. With the help of the agreement, both companies are expected to improve their market presence in the United States. In May 2019, the launch of the Radial 360 portfolio by Cordis, a Cardinal Health company, was announced. Radial 360 portfolio consists of Rain Sheath Trans radial Thin-Walled Introducer, Railway Sheath less Access System, RBL-TG and RBL-JK Universal Shapes for the Infiniti and Super Torque Plus Diagnostic Catheters, and Zephyr Vascular Compression Band offering a wide range of products for interventional cardiology procedures. In April 2019, a large-bore Manta Vascular Closure Devices by Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance. Manta Vascular Closure Devices is developed for closing large puncture sites in the femoral artery by using a polymer toggle attached to a collagen plug. Various Devices that the Market Leaders are Manufacturing are: Name of the produce Function Key Players The Mynx vascular closure devices. It is used for closing a small hole in blood vessels. Cordis, a Cardinal Health company. Terumo vascular closure devices. Used for creating a mechanical seal. Terumo Corporation. Venous vascular closure system. Designed to provide a resorbable Collagen Patch at the venotomy site to aid in achieving hemostasis. Cardivamedical. 3M Peak Assessment Tool. This 3M vascular access assessment tool empowers an individual in driving compliance by streamlining the entire review process & receiving customized as well as real-time feedback. 3M Frequently Asked Question About This Report What is the vascular closure devices market growth? The global vascular closure devices market is expected to grow at a compound annual growth rate (CAGR) of 7.0% from 2021 to 2030 to reach USD 1.761 billion by 2030. Who are the major key players? The major key players are Terumo Corporation, Abbott, Cardinal Health, Cardiva Medical, Inc, Medtronic Plc, Morris Innovative, Inc, Teleflex Incorporated, Merit Medical Systems, Inc, Vasorum Ltd, Medical, Inc, Vivasure Medical Ltd, Tricol Biomedical. What does a vascular closure device do? The vascular closure device is defined as a piece of collagen metallic clip specially designed to provide immediate sealing of the small puncture made in an artery after undergoing an angiogram. How big is the vascular closure devices market? The global vascular closure devices market size was $0.895 Bn in 2021 and is predicted to reach $1.761 Bn in 2030, at a CAGR of 7.0%. Is vascular damage reversible? No, the vascular damage is not reversible. Source https://www.cdc.gov/ http://www.heart.org/ https://www.hsph.harvard.edu/obesity-prevention-source/obesity-trends/obesity-rates-worldwide/ https://www.un.org/en/desa 1. Introduction 1.1. Study Objective 1.2. market Definition 1.3. Study Scope 1.3.1. markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing market Size by Top-Down Analysis 2.5. market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 market Summary 4. Industry Outlook 4.1 market Snapshot 4.2 Global Vascular Closure Devices market 4.2.1 Global market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Market, by Region, 2021-2030 (USD Million) 4.4 By Type Business Analysis 4.4.1 Market, By Type, 2021-2030 (USD Million) 4.5 By Access Business Analysis 4.5.1 Market, By Access, 2021-2030 (USD Million) 4.6 Application Business Analysis 4.6.1 Market, By Procedure, 2021-2030 (USD Million) 4.7 Value Chain Analysis 4.8 market Variable Analysis 4.8.1 market Drivers Analysis 4.8.2 market Restraints Analysis 4.9Business Environment Analysis Tool 4.9.1 PEST analysis 4.9.2 Porter’s analysis 4.10 Penetration & Growth Prospect Mapping 5. market Dynamics 5.1. Introduction 5.2. market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Application Analysis 5.11.1. Trends in Application (2014-2020) 5.11.2. Trends in Application (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Vascular Closure Device Manufacturing Sites, Area Served, Product By Type 6.3. Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Passive Approximators 7.3.1. Passive Approximators market, 2021-2030 (USD Million) 7.4. Collagen Plugs 7.4.1. Collagen Plugs market, 2021-2030 (USD Million) 7.5. A sealant or Gel-based Devices 7.5.1. A sealant or Gel-based Devices market, 2021-2030 (USD Million) 7.6. Compression Assist Devices 7.6.1. Compression Assist Devices market, 2021-2030 (USD Million) 7.7. Active Approximators 7.7.1. Active Approximators market, 2021-2030 (USD Million) 7.8. Suture-based Devices 7.8.1. Suture-based Devices market, 2021-2030 (USD Million) 7.9. Clip-based Devices 7.9.1. Clip-based Devices market, 2021-2030 (USD Million) 7.10. External Hemostatic Devices 7.10.1. External Hemostatic Devices market, 2021-2030 (USD Million) 8. Global Market: By Access Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Femoral Access 8.3.1. Femoral Access market, 2021-2030 (USD Million) 8.4. Radial Access 8.4.1. Radial Access market, 2021-2030 (USD Million) 9. Global Market: By Procedure Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Interventional Cardiology 9.3.1. Interventional Cardiology market, 2021-2030 (USD Million) 9.4. Interventional Radiology/Vascular 9.4.1. Interventional Radiology/Vascular market, 2021-2030 (USD Million) 10. Global Market: Regional Outlook 10.1 North America 10.1.1. North America By By Type, 2021-2030 (USD Million) 10.1.2. North America By By Access, 2021-2030 (USD Million) 10.1.3. North America By Procedure, 2021-2030 (USD Million) 10.1.4. North America by Country, 2021-2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. By By Type, 2021-2030 (USD Million) 10.1.4.1.2. U.S. By Access, 2021-2030 (USD Million) 10.1.4.1.3. U.S. By Procedure, 2021-2030 (USD Million) 10.1.4.2.Canada 10.1.4.2.1. Canada By By Type, 2021-2030 (USD Million) 10.1.4.2.2. Canada By By Access, 2021-2030 (USD Million) 10.1.4.2.3. Canada By Procedure, 2021-2030 (USD Million) 10.2. Europe 10.2.1. Europe By Type, 2021-2030 (USD Million) 10.2.2. Europe By Access, 2021-2030 (USD Million) 10.2.3. Europe By Procedure, 2021-2030 (USD Million) 10.2.4. Europe by country, 2021-2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K By Type, 2021-2030 (USD Million) 10.2.4.1.2. U.K. By Access, 2021-2030 (USD Million) 10.2.4.1.3. U.K. By Procedure, 2021-2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany By Type, 2021-2030 (USD Million) 10.2.4.2.2. Germany By Access, 2021-2030 (USD Million) 10.2.4.2.3. Germany By Procedure, 2021-2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France By Type, 2021-2030 (USD Million) 10.2.4.3.2. France By Access, 2021-2030 (USD Million) 10.2.4.3.3. France By Procedure, 2021-2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe By Type, 2021-2030 (USD Million) 10.2.4.4.2. Rest of Europe By Access, 2021-2030 (USD Million) 10.2.4.4.3. Rest of Europe By Procedure, 2021-2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific By Type, 2021-2030 (USD Million) 10.3.2. Asia Pacific By By Access, 2021-2030 (USD Million) 10.3.3. Asia Pacific By Procedure, 2021-2030 (USD Million) 10.3.4. Asia Pacific by country, 2021-2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China By Type, 2021-2030 (USD Million) 10.3.4.1.2. China By Access, 2021-2030 (USD Million) 10.3.4.1.3. China By Procedure, 2021-2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India By Type, 2021-2030 (USD Million) 10.3.4.2.2. India By Access, 2021-2030 (USD Million) 10.3.4.2.3. India By Procedure, 2021-2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan By Type, 2021-2030 (USD Million) 10.3.4.3.2. Japan By Access, 2021-2030 (USD Million) 10.3.4.3.3. Japan By Procedure, 2021-2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea By Type, 2021-2030 (USD Million) 10.3.4.4.2. South Korea By Access, 2021-2030 (USD Million) 10.3.4.4.3. South Korea By Procedure, 2021-2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC By Type, 2021-2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC By Access, 2021-2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC By Procedure, 2021-2030 (USD Million) 10.4. Latin America 10.4.1. Latin America By Type, 2021-2030 (USD Million) 10.4.2. Latin America By Access, 2021-2030 (USD Million) 10.4.3. Latin America By Procedure, 2021-2030 (USD Million) 10.4.4. Latin America by country, 2021-2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil By Type, 2021-2030 (USD Million) 10.4.4.1.2. Brazil By Access, 2021-2030 (USD Million) 10.4.4.1.3. Brazil By Procedure, 2021-2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico By Type, 2021-2030 (USD Million) 10.4.4.2.2. Mexico By Access, 2021-2030 (USD Million) 10.4.4.2.3. Mexico By Procedure, 2021-2030 (USD Million) 10.4.4.3. Rest of Latin America 10.4.4.3.1. Rest of the Latin America By Type, 2021-2030 (USD Million) 10.4.4.3.2. Rest of the Latin America By Access, 2021-2030 (USD Million) 10.4.4.3.3. Rest of the Latin America By Procedure, 2021-2030 (USD Million) 10.5. LAMEA 10.5.1. LAMEA By Type, 2021-2030 (USD Million) 10.5.2. LAMEA By Access, 2021-2030 (USD Million) 10.5.3. LAMEA By Procedure, 2021-2030 (USD Million) 10.5.4. LAMEA by Region, 2021-2030 (USD Million) 11. Competitive Landscape 11.1 Terumo Corporation 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. ProductPortfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. ABBOTT 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. CARDINAL HEALTH 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. CARDIVA MEDICAL, INC 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. MEDTRONIC PLC 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. Morris Innovative, Inc 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. Teleflex Incorporated 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. Merit Medical Systems, Inc. 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development 11.9. Vasorum Ltd 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 11.10. Medical, Inc 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Business Strategy & Recent Development 11.11. Vivasure Medical Ltd 11.11.1. Company overview 11.11.2. Financial performance 11.11.3. Product Portfolio Analysis 11.11.4. Business Strategy & Recent Development 11.12. Tricol Biomedical. 11.12.1. Company overview 11.12.2. Financial performance 11.12.3. Product Portfolio Analysis 11.12.4. Business Strategy & Recent Development List of Tables (56 Tables) TABLE 1. By Type, 2021-2030 (USD Million) TABLE 2. FOR Passive Approximators, BY REGION, 2021-2030 (USD Million) TABLE 3. FOR Collagen Plugs, BY REGION, 2021-2030 (USD Million) TABLE 4. FOR A sealant or Gel-based Devices, BY REGION, 2021-2030 (USD Million) TABLE 5. FOR Compression Assist Devices, BY REGION, 2021-2030 (USD Million) TABLE 6. FOR Active Approximators, BY REGION, 2021-2030 (USD Million) TABLE 7. FOR Suture-based Devices, BY REGION, 2021-2030 (USD Million) TABLE 8. FOR Clip-based Devices, BY REGION, 2021-2030 (USD Million) TABLE 9. FOR A External Hemostatic Devices, BY REGION, 2021-2030 (USD Million) TABLE 10. By Access, 2021-2030 (USD Million) TABLE 11. FOR Femoral Access, BY REGION, 2021-2030 (USD Million) TABLE 12. FOR Radial Access, BY REGION, 2021-2030 (USD Million) TABLE 13. BY PROCEDURE, 2021-2030 (USD Million) TABLE 14. FOR Interventional Cardiology, BY REGION, 2021-2030 (USD Million) TABLE 15. FOR Interventional Radiology/Vascular, BY REGION, 2021-2030 (USD Million) TABLE 16. BY REGION, 2021-2030 (USD Million) TABLE 17. NORTH AMERICA BY COUNTRY, 2021-2030 (USD Million) TABLE 18. NORTH AMERICA By Type, 2021-2030 (USD Million) TABLE 19. NORTH AMERICA By Access, 2021-2030 (USD Million) TABLE 20. NORTH AMERICA BY PROCEDURE, 2021-2030 (USD Million) TABLE 21. EUROPE BY COUNTRY, 2021-2030 (USD Million) TABLE 22. EUROPE By Type, 2021-2030 (USD Million) TABLE 23. EUROPE By Access, 2021-2030 (USD Million) TABLE 24. EUROPE BY PROCEDURE, 2021-2030 (USD Million) TABLE 25. ASIA-PACIFIC BY COUNTRY, 2021-2030 (USD Million) TABLE 26. ASIA-PACIFIC By Type, 2021-2030 (USD Million) TABLE 27. ASIA-PACIFIC By Access, 2021-2030 (USD Million) TABLE 28. ASIA-PACIFIC BY PROCEDURE, 2021-2030 (USD Million) TABLE 29. LAMEA BY COUNTRY, 2021-2030 (USD Million) TABLE 30. LAMEA By Type, 2021-2030 (USD Million) TABLE 31. LAMEA By Access, 2021-2030 (USD Million) TABLE 32. LAMEA BY PROCEDURE, 2021-2030 (USD Million) TABLE 33. Terumo Corporation: COMPANY SNAPSHOT TABLE 34. Terumo Corporation: OPERATING SEGMENTS TABLE 35. ABBOTT: COMPANY SNAPSHOT TABLE 36. ABBOTT: OPERATING SEGMENTS TABLE 37. CARDINAL HEALTH: COMPANY SNAPSHOT TABLE 38. CARDINAL HEALTH: OPERATING SEGMENTS TABLE 39. CARDIVA MEDICAL, INC : COMPANY SNAPSHOT TABLE 40. CARDIVA MEDICAL, INC : OPERATING SEGMENTS TABLE 41. MEDTRONIC PLC: COMPANY SNAPSHOT TABLE 42. MEDTRONIC PLC: OPERATING SEGMENTS TABLE 43. Morris Innovative, Inc: COMPANY SNAPSHOT TABLE 44. Morris Innovative, Inc: OPERATING SEGMENTS TABLE 45. Teleflex Incorporated: COMPANY SNAPSHOT TABLE 46. Teleflex Incorporated: OPERATING SEGMENTS TABLE 47. Merit Medical Systems, Inc: COMPANY SNAPSHOT TABLE 48. Merit Medical Systems, Inc: OPERATING SEGMENTS TABLE 49. Vasorum Ltd: COMPANY SNAPSHOT TABLE 50. Vasorum Ltd: OPERATING SEGMENTS TABLE 51. Medical, Inc: COMPANY SNAPSHOT TABLE 52. Medical, Inc: OPERATING SEGMENTS TABLE 53. Vivasure Medical Ltd: COMPANY SNAPSHOT TABLE 54. Vivasure Medical Ltd: OPERATING SEGMENTS TABLE 55. Tricol Biomedical: COMPANY SNAPSHOT TABLE 56. Tricol Biomedical: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries Figure 4 Research Methodology: Hypothesis Building Figure 5 Product-Based Estimation Figure 6 Top 12 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Vascular Closure Devices, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Vascular Closure Devices, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 By Access, 2019 vs. 2025 (USD Million) Figure 12 Share, By Procedure, 2019 vs. 2025 (USD Million) Figure 13 Share, By Type, 2019 vs. 2025 (USD Million) Figure 14 Geographical Snapshot Figure 15 Passive Approximators to Witness Higher CAGR in the Type Segment during Forecast Period. Figure 16 Interventional Radiology/Vascular to Witness Higher CAGR in the Interventional cardiology Application Segment during Forecast Period. Figure 17 Femoral Access to Witness Higher CAGR in the Access Segment during Forecast Period. Figure 18 North America Region Accounted for the Largest Share, By Regional Basis, in 2019 Figure 19 Drivers, Restraints, Opportunities, and Challenges Figure 20 North American Snapshot Figure 21 Asia Pacific Snapshot Figure 22 Vendor Dive: Evaluation Overview